Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Retained Earnings: 2022-2024

Historic Retained Earnings for Praxis Precision Medicines (PRAX) over the last 3 years, with Dec 2024 value amounting to -$836.7 million.

  • Praxis Precision Medicines' Retained Earnings fell 41.37% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 41.37%. This contributed to the annual value of -$836.7 million for FY2024, which is 27.96% down from last year.
  • Latest data reveals that Praxis Precision Medicines reported Retained Earnings of -$836.7 million as of FY2024, which was down 27.96% from -$653.9 million recorded in FY2023.
  • Over the past 5 years, Praxis Precision Medicines' Retained Earnings peaked at -$530.6 million during FY2022, and registered a low of -$836.7 million during FY2024.
  • Moreover, its 3-year median value for Retained Earnings was -$653.9 million (2023), whereas its average is -$673.8 million.
  • Data for Praxis Precision Medicines' Retained Earnings shows a maximum YoY dropped of 27.96% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Praxis Precision Medicines' Retained Earnings stood at -$530.6 million in 2022, then fell by 23.23% to -$653.9 million in 2023, then fell by 27.96% to -$836.7 million in 2024.